MIM
MNKD icon

MetLife Investment Management’s MannKind Corp MNKD Stock Holding History

MetLife Investment Management’s Portfolio MNKD Stock Details MNKD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$766K Buy
179,916
+36,676
+26% +$119K ﹤0.01% 1663
2026
Q1 		$351K Sell
143,240
-11,014
-7% -$49.1K ﹤0.01% 1929
2025
Q4 		$875K Sell
154,254
-16,756
-10% -$92.3K ﹤0.01% 1507
2025
Q3 		$918K Sell
171,010
-10,156
-6% -$44.6K ﹤0.01% 1497
2025
Q2 		$678K Buy
181,166
+22,290
+14% +$98.2K ﹤0.01% 1528
2025
Q1 		$799K Buy
158,876
+395
+0.2% +$2.21K ﹤0.01% 1474
2024
Q4 		$1.02M Buy
158,481
+5,110
+3% +$34.3K 0.01% 1402
2024
Q3 		$965K Hold
153,371
– – 0.01% 1406
2024
Q2 		$801K Buy
153,371
+21,844
+17% +$99.1K ﹤0.01% 1467
2024
Q1 		$596K Sell
131,527
-1,907
-1% -$7.49K ﹤0.01% 1582
2023
Q4 		$486K Hold
133,434
– – ﹤0.01% 1699
2023
Q3 		$551K Hold
133,434
– – ﹤0.01% 1573
2023
Q2 		$543K Buy
133,434
+9,221
+7% +$38.5K ﹤0.01% 1643
2023
Q1 		$509K Sell
124,213
-9,207
-7% -$44.4K ﹤0.01% 1627
2022
Q4 		$703K Hold
133,420
– – 0.01% 1421
2022
Q3 		$412K Buy
133,420
+20,487
+18% +$77.2K ﹤0.01% 1779
2022
Q2 		$430K Sell
112,933
-23,921
-17% -$87.9K ﹤0.01% 1771
2022
Q1 		$504K Buy
136,854
+68,352
+100% +$250K ﹤0.01% 1771
2021
Q4 		$299K Sell
68,502
-18,896
-22% -$87.4K ﹤0.01% 1816
2021
Q3 		$380K Buy
87,398
+21,868
+33% +$98.5K ﹤0.01% 1690
2021
Q2 		$357K Sell
65,530
-25,218
-28% -$109K ﹤0.01% 1781
2021
Q1 		$356K Buy
90,748
+17,480
+24% +$71.7K ﹤0.01% 1717
2020
Q4 		$229K Buy
73,268
+26,030
+55% +$68.3K ﹤0.01% 1907
2020
Q3 		$88.8K Sell
47,238
-45,671
-49% -$79K ﹤0.01% 2236
2020
Q2 		$163K Hold
92,909
– – ﹤0.01% 2017
2020
Q1 		$95.7K Buy
92,909
+64,524
+227% +$87.2K ﹤0.01% 2100
2019
Q4 		$36.6K Sell
28,385
-70,926
-71% -$90.8K ﹤0.01% 2286
2019
Q3 		$124K Buy
99,311
+16,825
+20% +$19.6K ﹤0.01% 2211
2019
Q2 		$94.9K Sell
82,486
-164,972
-67% -$228K ﹤0.01% 2381
2019
Q1 		$487K Buy
+247,458
New +$392K ﹤0.01% 2060
2018
Q3 		– Sell
-74,268
Closed -$141K – 2623
2018
Q2 		$141K Buy
+74,268
New +$139K ﹤0.01% 2089

Other funds holding MNKD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
1WA
180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

MetLife Investment Management's MNKD Position: Q2 2026 in Review

MetLife Investment Management increased its MannKind Corp (MNKD) stake by 26% in Q2 2026, buying an estimated $119K and bringing the position to 179,916 shares worth $766K. The position accounts for ﹤0.01% of the portfolio, ranked #1663.

MetLife Investment Management first reported a position in MNKD in Q2 2018 and has held it in 31 quarters since. The position peaked at $1.02M in Q4 2024. 259 funds tracked by Wall St. Rank hold MNKD as of Q2 2026.

  • MetLife Investment Management held 179,916 shares of MannKind Corp worth $766K as of Q2 2026.
  • MetLife Investment Management bought 36,676 MannKind Corp shares in Q2 2026, an estimated $119K.
  • MannKind Corp made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #1663 holding.
  • MetLife Investment Management first reported a position in MannKind Corp in Q2 2018 and has held it in 31 quarters since.
  • MetLife Investment Management's MannKind Corp position peaked at $1.02M in Q4 2024.
  • 259 funds tracked by Wall St. Rank held MannKind Corp as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.